Literature DB >> 1459782

Persistence of immune response in human toxocariasis as measured by ELISA.

S Fenoy1, C Cuéllar, C Aguila, J L Guillén.   

Abstract

The antibody titer was followed in a group of patients, clinically diagnosed with toxocariasis, during a 5 year period. We observed that larvae can survive for at least 5 years in humans. Antigenic stimulation was enough to keep high levels of immunoglobulins over this period. Antibody levels decreased slowly and this pattern is similar to that shown by animal models.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459782     DOI: 10.1016/0020-7519(92)90067-u

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  5 in total

1.  Toxocara canis larvae reinfecting BALB/c mice exhibit accelerated speed of migration to the host CNS.

Authors:  Petra Kolbeková; David Větvička; Jan Svoboda; Karl Skírnisson; Markéta Leissová; Martin Syrůček; Helena Marečková; Libuše Kolářová
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

2.  Seroprevalence of Larval Toxocarosis in the Czech Republic.

Authors:  Katerina Skulinova; Jan Novak; Martin Kasny; Libuse Kolarova
Journal:  Acta Parasitol       Date:  2019-10-04       Impact factor: 1.440

3.  Seroprevalence of Antibodies to Toxocara Species in the United States and Associated Risk Factors, 2011-2014.

Authors:  Eugene W Liu; Holly M Chastain; Sun Hee Shin; Ryan E Wiegand; Deanna Kruszon-Moran; Sukwan Handali; Jeffrey L Jones
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Prevalence of Toxocara species infection in the U.S.: Results from the National Health and Nutrition Examination Survey, 2011-2014.

Authors:  Aaron Farmer; Thomas Beltran; Young Sammy Choi
Journal:  PLoS Negl Trop Dis       Date:  2017-07-31

5.  Prolactin as immune cell regulator in Toxocara canis somatic larvae chronic infection.

Authors:  Víctor Hugo Del Río-Araiza; Karen Elizabeth Nava-Castro; Fernando Alba-Hurtado; Andrés Quintanar-Stephano; Hugo Aguilar-Díaz; Marco Antonio Muñoz-Guzmán; Pedro Ostoa-Saloma; María Dolores Ponce-Regalado; Jorge Morales-Montor
Journal:  Biosci Rep       Date:  2018-07-31       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.